Education and Training
The Dynamics of Human Atrial Fibrillation
The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Eligibility
Inclusion Criteria:
- Subjects will be patients undergoing electrophysiology study and ablation for
paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1
anti-arrhythmic drug.
Ages Eligible for Study
21 Years - 80 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Kathleen Mills
(858) 449-3252
Not Recruiting